The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

Bibliographic details

Authors

J. M. Siller-Matula, M. Unverdorben, C. C. Wang, Y. Koretsune, Ladislav Pecen, A. Borrow, C. Chen, P. Kirchhof, R. De Caterina

Publication year

2022

Publication type

Abstrakt

Periodical

European Heart Journal

Bibliographic citation

SILLER-MATULA, J. M., UNVERDORBEN, M., WANG, C. C., KORETSUNE, Y., PECEN, Ladislav, BORROW, A., CHEN, C., KIRCHHOF, P., DE CATERINA, R. The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure. European Heart Journal. 2022, 43(Suppl. 2), 2700-2700. ISSN 0195-668X. E-ISSN 1522-9645
Dostupné z: doi:10.1093/eurheartj/ehac544.2700

DOI

10.1093/eurheartj/ehac544.2700

ID

572207